Diabetes Management at the Pharmacy: Interventions, Adherence, and Technology
A Special Issue of Pharmacy (ISSN 2226-4787) belonging to the section "Pharmacy Practice and Practice-Based Research".
Deadline for manuscript submissions: 15 October 2026 | Viewed by 4483
Editor
Special Issue Information
Dear Colleagues,
Diabetes mellitus represents a global health challenge, requiring continuous, lifelong management. Pharmacists, with their accessibility and expertise, are uniquely positioned to bridge gaps in the healthcare system and play a pivotal role in improving diabetes care. The evolving scope of pharmacy practice now extends beyond dispensing to include direct patient care services, chronic disease management, and the integration of innovative technologies. This shift is expected to enhance patient education, improve medication adherence, and lead to better overall health outcomes. However, the real-world impact, scalability, and sustainability of these pharmacy-based interventions require further robust investigation. This Special Issue aims to provide a comprehensive evidence base that informs clinical practice, health policy, and future research to optimise patient-centred diabetes care.
We welcome the submission of original research articles, insightful perspectives, and review articles that address, but are not limited to, the following themes:
- Pharmacist-Led Interventions and Services:
- Clinical outcomes of structured diabetes education, counselling, and management programmes.
- Models for point-of-care testing (e.g., HbA1c, lipid profiling) and their impact on clinical decision making.
- Collaborative Drug Therapy Management and pharmacist-prescribing initiatives for diabetes medications.
- Screening and management of diabetes-related complications (e.g., hypertension, neuropathy, foot care).
- Implementation science: studies on the scalability, sustainability, and barriers to implementing diabetes services in diverse pharmacy practice settings (community, clinic, hospital).
- Medication and Lifestyle Adherence:
- Studies evaluating the effectiveness of adherence-enhancing programmes.
- Analysis of factors influencing adherence to antidiabetic medications, glucose monitoring, and lifestyle recommendations.
- The role of the pharmacist in managing therapeutic inertia and facilitating timely treatment intensification.
- Economic impact of improved adherence within pharmacist-managed care models.
- Technology and Innovation:
- The use of telehealth and telepharmacy for remote diabetes monitoring and consultation.
- Evaluation of mobile health (mHealth) applications, wearable devices, and digital tools for patient self-management and data sharing with pharmacists.
- The integration of pharmacy data with electronic health records (EHRs) to improve care coordination.
- Artificial intelligence (AI) and clinical decision support systems for identifying at-risk patients and optimising medication regimens in pharmacy practice.
- Assessing patient and pharmacist perceptions, usability, and digital literacy regarding new technologies.
Dr. Mohamed Hassan Elnaem
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- adherence
- digital health
- pharmacist-led
- interventions
- community pharmacy
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
